CIK 0001701108
- Non-accelerated filer
- Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $42,485
- in 1 filing
Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-07-05 | Larkin Cristina Chief Operating Officer | Sale | −4,000 | $17.50 | $70K | 1,500 |
| 2018-07-05 | Larkin Cristina Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,000 | 20,434 | ||
| 2018-07-05 | Sendek Joel Chief Financial Officer | Exercise or conversion | +2,000 | $5.90 | $12K | 17,181 |
| 2018-07-05 | Sendek Joel Chief Financial Officer | Sale | −2,000 | $17.50 | $35K | 15,181 |
| 2018-07-05 | Sendek Joel Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,000 | 165,833 | ||
| 2018-07-05 | Mahadevia Ankit | Exercise or conversion | +3,076 | $5.90 | $18K | 68,893 |
| 2018-07-05 | Mahadevia Ankit | Sale | −3,076 | $17.62 | $54K | 65,817 |
| 2018-07-05 | Mahadevia Ankit | Exercise or conversion · Stock Option (Right to Buy) | −3,076 | 120,488 | ||
| 2018-06-05 | THOMAS FRANK E Director | Grant or award · Stock Option (right to buy) | +6,073 | 6,073 | ||
| 2018-06-05 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (right to buy) | +6,073 | 6,073 | ||
| 2018-06-05 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (right to buy) | +6,073 | 6,073 | ||
| 2018-06-05 | Breum Casper Director | Grant or award · Stock Option (right to buy) | +6,073 | 6,073 | ||
| 2018-06-05 | Deshpande Milind Director | Grant or award · Stock Option (right to buy) | +6,073 | 6,073 | ||
| 2018-06-05 | VINK PATRICK V.J.J. Director | Grant or award · Stock Option (right to buy) | +6,073 | 6,073 | ||
| 2018-03-30 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (right to buy) | +12,146 | 12,146 | ||
| 2018-01-04 | Melnick David A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2017-12-13 | Larkin Cristina Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +62,540 | 62,540 | ||
| 2017-12-13 | Sendek Joel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +27,795 | 27,795 | ||
| 2017-12-13 | Parr Thomas R JR Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +36,134 | 36,134 | ||
| 2017-12-13 | Mahadevia Ankit | Grant or award · Stock Option (Right to Buy) | +125,079 | 125,079 |
Page 15 of 17 · 340 trades